New drug combo shows promise for hard-to-treat breast cancers
Disease control
Ongoing
This study tests a combination of three drugs (cisplatin, romidepsin, and nivolumab) in people with advanced triple-negative breast cancer or breast cancer linked to BRCA gene mutations. The goal is to see if the combination can shrink tumors and control the disease. About 51 adu…
Phase: PHASE1, PHASE2 • Sponsor: Priyanka Sharma • Aim: Disease control
Last updated May 22, 2026 14:03 UTC